Add to ORKGFrom 11th international annual meeting of the German Society of Nuclear Medicine; Athens, Greece (24 Sep 1973). The development of a number of new technetium-99m-labeled radiopharmaceuticals for use in scintiscanning is described. The effectiveness of colloids, chelates, and complexes that localize in a variety of body organs is discussed. The use of /sup 99m/Tc-labeled red blood cells for cardiovascular diagnostics is discussed. (CH
Soon after the discovery of radioactivity it was shown that radionuclides can be used both for diagn...
During the past few years a large part of the radiochemical research carried out at Lucas Heights h...
This book is part of a series mainly devoted to new developments in radio pharmaceuticals. The focus...
Radiopharmaceuticals are radioactive compounds which have a bound radionuclide in their structure. I...
This publication provides a broad overview of the current status and future prospects of technetium-...
Even today, techentium-99m represents the radionuclide of choice for diagnostic radio-imaging applic...
The list of the developed Tc-99m-kits in our research center is given, while the whole research work...
Technetium-99m has been found physically opti mal for scintigraphy (1,2). Readily obtainable from a ...
Erythrocytes, leukocytes, and tumor cells were labeled with /sup 99m/Tc to take advantage of the ide...
Radioisotope therapy began in 1942 with the use of /sup 131/I for Graves disease and /sup 32/P for ...
Nuclear medicine is a rapidly developing field which focuses on the imaging of physiological process...
This project is about synthesis and evaluation of novel Tc-99m complexes as potential radiotracers f...
Over the past 40 years, nuclear medicine has grown to be the largest non-invasive diagnostic and the...
Radiopharmaceuticals contain a radionuclide and an agent to direct the radionuclide to a receptor, a...
Since its introduction in 1976 as an imaging procedure, the use of labelled leucocyte scintigraphy h...
Soon after the discovery of radioactivity it was shown that radionuclides can be used both for diagn...
During the past few years a large part of the radiochemical research carried out at Lucas Heights h...
This book is part of a series mainly devoted to new developments in radio pharmaceuticals. The focus...
Radiopharmaceuticals are radioactive compounds which have a bound radionuclide in their structure. I...
This publication provides a broad overview of the current status and future prospects of technetium-...
Even today, techentium-99m represents the radionuclide of choice for diagnostic radio-imaging applic...
The list of the developed Tc-99m-kits in our research center is given, while the whole research work...
Technetium-99m has been found physically opti mal for scintigraphy (1,2). Readily obtainable from a ...
Erythrocytes, leukocytes, and tumor cells were labeled with /sup 99m/Tc to take advantage of the ide...
Radioisotope therapy began in 1942 with the use of /sup 131/I for Graves disease and /sup 32/P for ...
Nuclear medicine is a rapidly developing field which focuses on the imaging of physiological process...
This project is about synthesis and evaluation of novel Tc-99m complexes as potential radiotracers f...
Over the past 40 years, nuclear medicine has grown to be the largest non-invasive diagnostic and the...
Radiopharmaceuticals contain a radionuclide and an agent to direct the radionuclide to a receptor, a...
Since its introduction in 1976 as an imaging procedure, the use of labelled leucocyte scintigraphy h...
Soon after the discovery of radioactivity it was shown that radionuclides can be used both for diagn...
During the past few years a large part of the radiochemical research carried out at Lucas Heights h...
This book is part of a series mainly devoted to new developments in radio pharmaceuticals. The focus...